Signaling pathways
-
F1642 Anti-CDH17/Cadherin-17 Antibody (10C12)Summary: Anti-CDH17/Cadherin-17 Antibody (10C12) -
F1643 Anti-CEACAM6/CD66c Antibody (NEO-201)Summary: Anti-CEACAM6/CD66c Antibody (NEO-201) -
F1644 Anti-Clathrin Heavy Chain/CHC Antibody (Academia Sinica patent anti-Clathrin Heavy Chain)Summary: Anti-Clathrin Heavy Chain/CHC Antibody (Academia Sinica patent anti-Clathrin Heavy Chain) -
F1645 Anti-CLDN6 Antibody (IMAB027)Summary: Anti-CLDN6 Antibody (IMAB027) -
F1646 Anti-Complement C5aR1 Antibody (G2_anti-C5aR)Summary: Anti-Complement C5aR1 Antibody (G2_anti-C5aR) -
F1647 Anti-Complement Factor P/Properdin Antibody (Novelmed patent anti-Properdin)Summary: Anti-Complement Factor P/Properdin Antibody (Novelmed patent anti-Properdin) -
F1648 Anti-CSF3R/G-CSFR Antibody (CSL patent anti-G-CSFR)Summary: Anti-CSF3R/G-CSFR Antibody (CSL patent anti-G-CSFR) -
F1649 Anti-CXC-ELR Antibody (Lilly patent anti-Pan-ELR+)Summary: Anti-CXC-ELR Antibody (Lilly patent anti-Pan-ELR+) -
F1650 Anti-CXCL9 Antibody (Novimmune patent anti-CXCL9)Summary: Anti-CXCL9 Antibody (Novimmune patent anti-CXCL9) -
F1651 Anti-DSG3 Antibody (Forerunner patent anti-DSG3)Summary: Anti-DSG3 Antibody (Forerunner patent anti-DSG3)